Form 8-K - Current report:
SEC Accession No. 0001193125-20-139458
Filing Date
2020-05-12
Accepted
2020-05-11 20:19:09
Documents
15
Period of Report
2020-05-11
Items
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d842701d8k.htm   iXBRL 8-K 36915
2 EX-99.1 d842701dex991.htm EX-99.1 14084
3 EX-99.2 d842701dex992.htm EX-99.2 12783
7 GRAPHIC g842701g0509092532745.jpg GRAPHIC 2724
  Complete submission text file 0001193125-20-139458.txt   203494

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA bhc-20200511.xsd EX-101.SCH 2735
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bhc-20200511_lab.xml EX-101.LAB 18083
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bhc-20200511_pre.xml EX-101.PRE 11374
16 EXTRACTED XBRL INSTANCE DOCUMENT d842701d8k_htm.xml XML 3651
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 20866751
SIC: 2834 Pharmaceutical Preparations